UNSPSC 51161513: Diprophylline or dyphylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C10H14N4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 263T0E9RR9, chemically known as 1,3-dimethyl-7-(2,3-dihydroxypropyl)xanthine but generally known as diprophylline, which bears US NIH Compound Identifier 3182. European Medicines Agency schedules Diprophylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07225MIG. The term DIPROPHYLLINE is an International Non-Proprietary Name.

UNSPSC 51161513 Diprophylline or dyphylline is a Commodity code covering a bronchodilator pharmaceutical used in respiratory treatment. The code captures procurement of this specific active pharmaceutical ingredient and finished formulations (tablets, elixirs, injectable solutions) by state and local health agencies, corrections departments, school districts with health clinics, and public hospital systems. Dyphylline is a xanthine derivative prescribed for asthma, chronic obstructive pulmonary disease, and related airway obstruction, and state and local buyers source it through direct pharmaceutical suppliers, group purchasing organizations (GPOs), and state formulary contracts. The drug is a lower-profile therapeutic within the broader respiratory-medication class, so it typically appears on procurement lists as part of larger pharmaceutical catalogs rather than as a standalone acquisition focus.

The recent-opportunities block contains no posted solicitations under this code. State and local procurement activity under UNSPSC 51161513 does not surface in the available recent data, limiting visibility into current issuing bodies, response dates, or geographic concentration.